Last reviewed · How we verify
NCT05010278: ERASME
Evaluation of Factors Associated With Return to Sports Activity Six Months After Anterior Shoulder Stabilisation With Latarjet.
trial testing Latarjet in Shoulder Luxation in 118 participants. Completed in 31 January 2022.
31 January 2022
Quick facts
| Lead sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 118 |
| Start date | 30 September 2021 |
| Primary completion | 31 January 2022 |
| Estimated completion | 31 January 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Latarjet
Conditions studied
- Shoulder Luxation — all drugs for Shoulder Luxation →
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →
Who can join
18 and older, any sex, with Shoulder Luxation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
On a population of sports patients who had undergone a Latarjet operation for post-traumatic anterior shoulder instability, reviewed in consultation 6 months after the operation as part of an ordinary follow-up and divided into two groups according to their current sports practice. Group 1: "SUCCESS": return to the same level in the same sport. Group 2: "FAILURE": return to the same sport with a reduced level or change of sport or significant reduction or cessation of sporting activity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05010278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Latarjet
Trials testing the same drug.
- NCT04809064 — Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial · recruiting
Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials
Trials by the same sponsor.
- NCT07274657 — Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) · NA · not yet recruiting
- NCT07271277 — 3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study · NA · not yet recruiting
- NCT07263997 — Assessment of a New Traction Device in Submucosal Dissection of Colorectal Lesions · NA · not yet recruiting
- NCT07249645 — Description of Return to Sport in Amateur Athletes Who Underwent Several Functional Tests (K-STARTS, Vertical Jumps and · NA · not yet recruiting
- NCT06678646 — Ultrasound-guided Release of the Median Nerve at the Elbow in Patients With Lacertus Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05010278 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GCS Ramsay Santé pour l'Enseignement et la Recherche
- Last refreshed: 1 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05010278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing